Sequencing.com, a Los Angeles, CA-based direct-to-consumer DNA interpretation company, raised $5m in funding
The round was led by Lerer Hippeau with participation from Red Sea Ventures, Global Founders Capital, XRC Labs, Correlation Ventures, Red Antler, Mucker Capital, and Gaingels.
The company intends to use the funds to build upon and enhance its DNA technology.
Led by CEO Dr. Brandon Colby, Sequencing.com provides what the customer needs to access and understand their genes. This includes free, unlimited storage of DNA data as well as tools and enhanced reports that transform DNA data into clear solutions for better health. The company has also recently upgraded its two proprietary applications, Genome Explorer and Next-Gen Rare Disease Screen. Genome Explorer is an online browser and search engine for genomes that allows customers to easily access information and the latest research relevant to their DNA data. Next-Gen Rare Disease Screen gives customers the option to screen their genome for the risk of thousands of rare diseases, conditions, and traits.
The company’s team consists of US medical doctors, geneticists, bioinformatics experts, and software developers.
FinSMEs
09/11/2022